Text of the Scope of Gene Therapy that Can Be Financed by the California Stem Cell Agency

Prior to voter approval of Proposition 14 of 2020, the California stem cell agency financed limited gene therapy research via a rarely used provision in the ballot measure (Proposition 71) that created the agency in 2004.

The provision allowed CIRM to fund any activities that its board defined as “vital research opportunities (VROs).”  On Nov. 15, 2018,…